Clinical Trials Browser

Non-Muscle Invasive Bladder Neoplasms × durvalumab × 1 year × Clear all

NCT06503614 2026-02-17

ENHANCE

Phase 2 Recruiting

Non-Muscle Invasive Bladder Neoplasms

NCT03528694 2025-11-25

POTOMAC

Phase 3 Active not recruiting

Non-Muscle Invasive Bladder Neoplasms